Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics.

Rodríguez-Rubio L, Martínez B, Donovan DM, Rodríguez A, García P.

Crit Rev Microbiol. 2013 Nov;39(4):427-34. doi: 10.3109/1040841X.2012.723675. Epub 2012 Sep 20. Review.

PMID:
22991936
2.

Endolysins as antimicrobials.

Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM.

Adv Virus Res. 2012;83:299-365. doi: 10.1016/B978-0-12-394438-2.00007-4. Review.

PMID:
22748813
3.

Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications.

Donovan DM.

Recent Pat Biotechnol. 2007;1(2):113-22. Review.

PMID:
19075835
4.

Bacteriophage endolysins as a novel class of antibacterial agents.

Borysowski J, Weber-Dabrowska B, Górski A.

Exp Biol Med (Maywood). 2006 Apr;231(4):366-77. Review.

PMID:
16565432
5.

Taking aim on bacterial pathogens: from phage therapy to enzybiotics.

Hermoso JA, García JL, García P.

Curr Opin Microbiol. 2007 Oct;10(5):461-72. Epub 2007 Sep 27. Review.

PMID:
17904412
6.

A novel type of peptidoglycan-binding domain highly specific for amidated D-Asp cross-bridge, identified in Lactobacillus casei bacteriophage endolysins.

Regulski K, Courtin P, Kulakauskas S, Chapot-Chartier MP.

J Biol Chem. 2013 Jul 12;288(28):20416-26. doi: 10.1074/jbc.M112.446344. Epub 2013 Jun 3.

7.

Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process.

Latka A, Maciejewska B, Majkowska-Skrobek G, Briers Y, Drulis-Kawa Z.

Appl Microbiol Biotechnol. 2017 Apr;101(8):3103-3119. doi: 10.1007/s00253-017-8224-6. Epub 2017 Mar 23. Review.

8.

Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.

Walmagh M, Briers Y, dos Santos SB, Azeredo J, Lavigne R.

PLoS One. 2012;7(5):e36991. doi: 10.1371/journal.pone.0036991. Epub 2012 May 15.

9.

Peptidoglycan hydrolytic activities associated with bacteriophage virions.

Moak M, Molineux IJ.

Mol Microbiol. 2004 Feb;51(4):1169-83.

10.

Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.

Schmelcher M, Shen Y, Nelson DC, Eugster MR, Eichenseher F, Hanke DC, Loessner MJ, Dong S, Pritchard DG, Lee JC, Becker SC, Foster-Frey J, Donovan DM.

J Antimicrob Chemother. 2015 May;70(5):1453-65. doi: 10.1093/jac/dku552. Epub 2015 Jan 27.

11.

Bacteriophage endolysins as novel antimicrobials.

Schmelcher M, Donovan DM, Loessner MJ.

Future Microbiol. 2012 Oct;7(10):1147-71. doi: 10.2217/fmb.12.97. Review.

12.

[Lysis of bacterial cells in the process of bacteriophage release--canonical and newly discovered mechanisms].

Woźnica WM, Bigos J, Łobocka MB.

Postepy Hig Med Dosw (Online). 2015 Jan 23;69:114-26. Review. Polish.

PMID:
25614679
13.

Recombinant bacteriophage lysins as antibacterials.

Fenton M, Ross P, McAuliffe O, O'Mahony J, Coffey A.

Bioeng Bugs. 2010 Jan-Feb;1(1):9-16. doi: 10.4161/bbug.1.1.9818. Review.

14.

Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity.

Schmelcher M, Tchang VS, Loessner MJ.

Microb Biotechnol. 2011 Sep;4(5):651-62. doi: 10.1111/j.1751-7915.2011.00263.x. Epub 2011 Apr 27.

15.

From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.

Gerstmans H, Rodríguez-Rubio L, Lavigne R, Briers Y.

Biochem Soc Trans. 2016 Feb;44(1):123-8. doi: 10.1042/BST20150192. Review.

PMID:
26862197
16.

Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.

Rodríguez-Rubio L, Gutiérrez D, Donovan DM, Martínez B, Rodríguez A, García P.

Crit Rev Biotechnol. 2016;36(3):542-52. doi: 10.3109/07388551.2014.993587. Epub 2015 Jan 21.

PMID:
25603721
17.

[Phage lytic enzymes--new hope in battle against bacterial infections].

Niczyporuk JS, Bartoszcze M.

Przegl Epidemiol. 2007;61(4):713-21. Review. Polish.

PMID:
18572503
18.

Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88.

Rodríguez L, Martínez B, Zhou Y, Rodríguez A, Donovan DM, García P.

BMC Microbiol. 2011 Jun 17;11:138. doi: 10.1186/1471-2180-11-138.

19.

Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978.

Lai MJ, Soo PC, Lin NT, Hu A, Chen YJ, Chen LK, Chang KC.

Int J Antimicrob Agents. 2013 Aug;42(2):141-8. doi: 10.1016/j.ijantimicag.2013.04.022. Epub 2013 Jun 3.

PMID:
23742833
20.

A genetic screen to identify bacteriophage lysins.

Schuch R, Fischetti VA, Nelson DC.

Methods Mol Biol. 2009;502:307-19. doi: 10.1007/978-1-60327-565-1_18.

Supplemental Content

Support Center